|
HERC4 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.694000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.985600E-01 |
| Normal-vs-Stage2 |
6.465000E-01 |
| Normal-vs-Stage3 |
8.284800E-01 |
| Normal-vs-Stage4 |
7.174200E-01 |
| Stage1-vs-Stage2 |
4.980400E-01 |
| Stage1-vs-Stage3 |
9.965400E-01 |
| Stage1-vs-Stage4 |
4.853000E-01 |
| Stage2-vs-Stage3 |
5.436200E-01 |
| Stage2-vs-Stage4 |
8.557600E-01 |
| Stage3-vs-Stage4 |
5.965000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.227800E-01 |
| Normal-vs-AfricanAmerican |
6.946400E-01 |
| Normal-vs-Asian |
8.539900E-03 |
| Caucasian-vs-AfricanAmerican |
5.117600E-01 |
| Caucasian-vs-Asian |
3.222100E-02 |
| AfricanAmerican-vs-Asian |
2.252000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.343200E-01 |
| Normal-vs-Female |
3.566000E-01 |
| Male-vs-Female |
4.155900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.317600E-01 |
| Normal-vs-Age(41-60Yrs) |
5.919400E-01 |
| Normal-vs-Age(61-80Yrs) |
6.949800E-01 |
| Normal-vs-Age(81-100Yrs) |
5.358200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.031000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.410000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.952600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.660200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.290200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.575800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.072610E-01 |
| Normal-vs-Grade 2 |
4.238800E-01 |
| Normal-vs-Grade 3 |
1.950830E-01 |
| Normal-vs-Grade 4 |
7.619200E-01 |
| Grade 1-vs-Grade 2 |
1.937040E-01 |
| Grade 1-vs-Grade 3 |
1.507740E-02 |
| Grade 1-vs-Grade 4 |
2.534000E-01 |
| Grade 2-vs-Grade 3 |
1.677930E-02 |
| Grade 2-vs-Grade 4 |
6.980800E-01 |
| Grade 3-vs-Grade 4 |
1.565620E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.029800E-01 |
| Normal-vs-ccB subtype |
5.824400E-01 |
| ccA subtype-vs-ccB subtype |
2.517400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.894000E-01 |
| Normal-vs-N1 |
3.959000E-01 |
| N0-vs-N1 |
5.956200E-01 |
|
|
